| ID | 1607 |
|---|
| No | 1607 |
|---|
| Brand Name | ALILAROTINIB |
|---|
| Ingredients | LAROTRECTINIB SULFATE 100 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 30 CAPSULES/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF ADULT AND PEDIATRIC PATIENTS WITH SOLID TUMORS THAT HAVE A NEUROTROPHIC RECEPTOR TYROSINE KINASE GENE FUSION WITHOUT A KNOWN ACQUIRED RESISTANCE MUTATION, PATIENTS WITH LOCALLY ADVANCED, METASTATIC DISEASE, OR SURGICAL RESECTION THAT MAY LEAD TO SERIOUS COMPLICATION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | WHITE CAPSULE CONTAINS YELLOW POWDER |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 L 1228/24 |
|---|
| FDD Registration Date | 14/11/2024 |
|---|
| Expiry Date | 13/11/2029 |
|---|
